Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brostallicin vs Doxorubicin in Advanced Soft Tissue Sarcoma
NCT00410462Phase 2Unknown
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Oct 2006
- Primary completion
- Sep 2008
- Modality
- DNA Intercalators/Alkylators, Recombinant Proteins and Enzymes, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of brostallicin in soft tissue sarcoma (STS), sponsored by European Organisation for Research and Treatment of Cancer. Status: unknown.
02
Drugs
brostallicin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00410462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00410462.